The association between tumor mutational burden and prognosis is dependent on treatment context

[1]  Tao Wang,et al.  DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden , 2020, Cell reports medicine.

[2]  Nicolai J. Birkbak,et al.  The T cell differentiation landscape is shaped by tumour mutations in lung cancer , 2020, Nature Cancer.

[3]  M. Hernán,et al.  Why Test for Proportional Hazards? , 2020, JAMA.

[4]  Huiyan Luo,et al.  Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers. , 2019, Annals of translational medicine.

[5]  Ruizhu Zheng,et al.  Correlations between microsatellite instability and the biological behaviour of tumours , 2019, Journal of Cancer Research and Clinical Oncology.

[6]  M. Rubin,et al.  Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution. , 2019, JCO precision oncology.

[7]  V. Budach,et al.  Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group. , 2019, European journal of cancer.

[8]  A. Gonzalez-Perez,et al.  The mutational footprints of cancer therapies , 2019, bioRxiv.

[9]  J. Nieva,et al.  Impact of prior chemotherapy or radiation therapy on tumor mutation burden in NSCLC. , 2019, Journal of Clinical Oncology.

[10]  C. Brennan,et al.  Tumor mutational load predicts survival after immunotherapy across multiple cancer types , 2019, Nature Genetics.

[11]  A. Niemierko,et al.  Clinical Impact of Tumor Mutational Burden in Neuroblastoma. , 2018, Journal of the National Cancer Institute.

[12]  Yuki Matsumura,et al.  Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  Reporting for specific materials, systems and methods , 2018 .

[14]  Ahmet Zehir,et al.  Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data. , 2017, JCO precision oncology.

[15]  Ludmila V. Danilova,et al.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.

[16]  Donavan T. Cheng,et al.  Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.

[17]  M. Berger,et al.  DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma , 2017, Clinical Cancer Research.

[18]  Jay Shendure,et al.  Classification and characterization of microsatellite instability across 18 cancer types , 2016, Nature Medicine.

[19]  In-Hee Lee,et al.  Clonal evolution of glioblastoma under therapy , 2016, Nature Genetics.

[20]  J. Reis-Filho,et al.  Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival , 2016, Oncotarget.

[21]  Hanlee P. Ji,et al.  Pan-cancer analysis of the extent and consequences of intratumor heterogeneity , 2015, Nature Medicine.

[22]  S. Gabriel,et al.  Genomic correlates of response to CTLA-4 blockade in metastatic melanoma , 2015, Science.

[23]  Jens Schreiner,et al.  Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors , 2015, Cancer Immunology Research.

[24]  Donavan T. Cheng,et al.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.

[25]  J. Wolchok,et al.  Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.

[26]  Krishnendu Chatterjee,et al.  Evolutionary dynamics of cancer in response to targeted combination therapy , 2013, eLife.

[27]  R. Houlston,et al.  Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Martin A. Nowak,et al.  The role of chromosomal instability in tumor initiation , 2002, Proceedings of the National Academy of Sciences of the United States of America.